Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
15.05
-0.14 (-0.92%)
At close: Jun 16, 2026, 4:00 PM EDT
13.38
-1.67 (-11.10%)
After-hours: Jun 16, 2026, 7:56 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.67 billion as of June 16, 2026. Its market cap has increased by 268.08% in one year.
Market Cap
1.67B
Enterprise Value
1.40B
1-Year Change
268.08%
Ranking
Category
Stock Price
$15.05
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.67B, an increase of 56.51%. That is a compound annual growth rate of 10.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.67B | 26.14% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.55B |
| BioCryst Pharmaceuticals | 2.30B |
| Prestige Consumer Healthcare | 2.21B |
| Bausch Health Companies | 1.86B |
| HUTCHMED (China) | 1.85B |
| ANI Pharmaceuticals | 1.74B |
| Perrigo Company | 1.48B |
| Harrow | 1.45B |